Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Moxifloxacin.

× No keyword cloud information.

8 in total

1. Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis.

Authors: Stephanie Thee; Anthony J Garcia-Prats; Heather R Draper; Helen M McIlleron; Lubbe Wiesner; Sandra Castel; H Simon Schaaf; Anneke C Hesseling
Journal: Clin Infect Dis Date: 2014-10-30 Impact factor: 9.079

2. Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.

Authors: Paolo Denti; Anneke C Hesseling; Louvina E van der Laan; Anthony J Garcia-Prats; H Simon Schaaf; Tjokosela Tikiso; Lubbe Wiesner; Mine de Kock; Jana Winckler; Jennifer Norman; Helen McIlleron
Journal: Antimicrob Agents Chemother Date: 2018-01-25 Impact factor: 5.191

3. Efficacy of topically delivered moxifloxacin against wound infection by Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.

Authors: F Jacobsen; C Fisahn; M Sorkin; I Thiele; T Hirsch; I Stricker; T Klaassen; A Roemer; B Fugmann; L Steinstraesser
Journal: Antimicrob Agents Chemother Date: 2011-02-22 Impact factor: 5.191

4. Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.

Authors: Melisa Willby; R David Sikes; Seidu Malik; Beverly Metchock; James E Posey
Journal: Antimicrob Agents Chemother Date: 2015-06-22 Impact factor: 5.191

5. Pharmacokinetics of Second-Line Antituberculosis Drugs after Multiple Administrations in Healthy Volunteers.

Authors: Sang-In Park; Jaeseong Oh; Kyungho Jang; Jangsoo Yoon; Seol Ju Moon; Jong Sun Park; Jae Ho Lee; Junghan Song; In-Jin Jang; Kyung-Sang Yu; Jae-Yong Chung
Journal: Antimicrob Agents Chemother Date: 2015-05-18 Impact factor: 5.191

Review 6. Safety and tolerability profile of second-line anti-tuberculosis medications.

Authors: Geetha Ramachandran; Soumya Swaminathan
Journal: Drug Saf Date: 2015-03 Impact factor: 5.606

7. Prediction of Pharmacokinetics and Penetration of Moxifloxacin in Human with Intra-Abdominal Infection Based on Extrapolated PBPK Model.

Authors: LiQin Zhu; JianWei Yang; Yuan Zhang; YongMing Wang; JianLei Zhang; YuanYuan Zhao; WeiLin Dong
Journal: Korean J Physiol Pharmacol Date: 2015-02-25 Impact factor: 2.016

8. Synthesis, physicochemical characterization, toxicity and efficacy of a PEG conjugate and a hybrid PEG conjugate nanoparticle formulation of the antibiotic moxifloxacin.

Authors: Lesego L Tshweu; Mohamed A Shemis; Aya Abdelghany; Abdullah Gouda; Lynne A Pilcher; Nicole R S Sibuyi; Mervin Meyer; Admire Dube; Mohammed O Balogun
Journal: RSC Adv Date: 2020-05-26 Impact factor: 4.036

8 in total